Lesson plan

Tacedinaline

Tacedinaline ( , ; developmental code name CI-994), also known as N-acetyldinaline, is a histone deacetylase (HDAC) inhibitor and possible cognitive enhancer which is under development for the treatment of Alzheimer's disease. It was also under development as an antineoplastic agent for the treatment of various cancers, but development for these uses was discontinued. The drug is taken orally.

Back to article

Article summary

Tacedinaline ( , ; developmental code name CI-994), also known as N-acetyldinaline, is a histone deacetylase (HDAC) inhibitor and possible cognitive enhancer which is under development for the treatment of Alzheimer's disease. It was also under development as an antineoplastic agent for the treatment of various cancers, but development for these uses was discontinued. The drug is taken orally.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.